Angiogenesis imaging - We are developing targeted ultrasound contrast agents to detect neovascularization. We have chosen to target angiogenic receptors located exclusively on the endothelium, with the premise that detection of these receptors by imaging techniques will permit identification and localization of angiogenesis and monitoring of therapies.
The Center for Ultrasound Molecular Imaging and Therapeutics at UPMC is a multidisciplinary translational research facility designed to develop the science and technology of ultrasound contrast agents and ultrasound imaging systems with the goal of moving basic discoveries in ultrasound-based molecular imaging and treatments into clinical practice.
The Center for Ultrasound Molecular Imaging and Therapeutics is a program of UPMC and the University of Pittsburgh.